Various biomarkers are available to support the diagnosis of neurodegenerative diseases in
clinical and research settings. Among the molecular imaging biomarkers, amyloid-PET …

The recent commercialisation of the first disease-modifying drugs for Alzheimer's disease
emphasises the need for consensus recommendations on the rational use of biomarkers to …

The present procedural guidelines summarize the current views of the EANM Neuro-
Imaging Committee (NIC). The purpose of these guidelines is to assist nuclear medicine …

Aim The diagnosis, severity and extent of a sterile inflammation or a septic infection could be
challenging since there is not one single test able to achieve an accurate diagnosis. The …

Background: Mild cognitive impairment (MCI) is an important stage between the normal
cognitive decline of aging and dementia. The aim of this study was to compare and …

People with type 2 diabetes are at an increased risk of cognitive impairment and dementia
(including Alzheimer's disease), as well as subtle forms of cognitive dysfunction. Current …

Emerging evidence indicates that the etiologic agent responsible for coronavirus disease
2019 (COVID-19), can cause neurological complications. COVID-19 may induce cognitive …

Objective To consolidate current understanding of detection sensitivity of brain 18 F-FDG
PET scans in the diagnosis of autoimmune encephalitis and to define specific metabolic …

Germline mutations in cellular-energy associated genes have been shown to lead to various
monogenic disorders. Notably, mitochondrial disorders often impact skeletal muscle, brain …

Purpose The purpose of this study is to develop and validate a 3D deep learning model that
predicts the final clinical diagnosis of Alzheimer's disease (AD), dementia with Lewy bodies …